Confidential mandate

Agentic Product Capital and Inference Economics Adviser

Planned Hiring / New

Agentic Product Capital and Inference Economics Adviser mandate in Mumbai, India · AI SaaS

A six-month finance retainer will challenge agentic product capital allocation against inference and customer economics, testing monetisation durability and downside cash while leaving product deployment, pricing and binding budgets with authorised executives.

The mandate

The product-finance committee's standing question is how much capital to commit to agentic features when customer willingness to pay and inference burden evolve together. The adviser will challenge financial allocation, not the technical ambition of autonomy itself. The remit focuses on which economic assumptions justify investment and what evidence should be obtained before a larger commitment.

Four days monthly cover usage and commercial evidence, a targeted capital-case challenge and committee attendance. The meeting is included. A capital question receives acknowledgement within two working days and a documented view within four when the agreed data is available. Continuous infrastructure optimisation and product pricing execution are outside the retainer.

The finance challenge term opens on 19 October 2026 and lasts six months. Renewal requires the chair to identify further capital choices needing independent economic judgement. The adviser receives no line authority over products, and carries no executive responsibility for deployment or budgets. Product, infrastructure and finance leaders retain their approvals and operating obligations.

The sponsor supplies authorised cost scenarios, customer usage cohorts, pricing definitions and capital options. Advice must distinguish an inference-cost reduction that genuinely improves contribution from one achieved by weakening service value or shifting effort to support. Capital cases should expose usage distribution and downside cash rather than rely on one average customer behaving as expected.

Concurrent non-competing financial advice is permitted. Equity or remuneration from a reviewed infrastructure provider, an active investor or a directly competing agentic platform creates a conflict requiring disclosure and potential recusal. Procurement negotiation, fundraising placement and architecture design are excluded. The committee wants independent capital discipline without confusing a financial opinion with a technical deployment decision.

What you will own

  • Challenge capital cases against customer usage distributions and retained income, pressing sponsors to show where average economics conceal a material uneconomic cohort.
  • Test inference-cost proposals for service and support consequences, advising whether the apparent saving improves total contribution or merely shifts burden elsewhere.
  • Shape staged investment choices around paid-task retention and contribution thresholds, showing which cohort evidence warrants another learning tranche and which result should suspend scale expenditure.
  • Examine downside cash under heavier-than-planned agent activity, quantifying the usage and inference-cost combination that exhausts approved headroom and requires the committee to reconsider product funding.
  • Press owners to retain pricing and cost assumptions across updates, so later improvement cannot be claimed by silently redefining the original customer economics.
  • Review alternative capital uses for opportunity cost and reversibility, advising what evidence supports allocating scarce funding to this product rather than another option.
  • Record independent recommendations and conflict limits in a capital note, leaving pricing approval, infrastructure commitment and deployment decisions with authorised executives.

Candidate qualifications

  • Evidence senior technology business-finance judgement involving usage-sensitive costs and product capital choices. Explain an investment recommendation, the customer behaviour tested and why the preferred allocation changed.
  • Demonstrate unit-economics analysis beyond an average cost-per-request measure. Candidates should describe the distribution or contractual pattern that mattered and show how revenue, inference and support were evaluated together.
  • Provide a staged capital decision with explicit learning triggers. Explain what could be committed safely, what remained premature and what new evidence would justify a broader allocation.
  • Show independence from infrastructure, investor and competing product incentives. Describe a disclosed conflict or recusal and how confidential customer economics remained separated from concurrent assignments.
  • Be able to sustain four reserved days monthly and deliver usable financial advice under uncertain monetisation. Proven finance scope matters more than nominal technical authority. Candidates should show how a cost-saving hypothesis was rejected when it weakened service value, how the adverse effect was measured and why the financial recommendation did not become an unauthorised architecture instruction. Explain how the capital note treats a customer contract whose price is fixed while usage is not. Show the downside evidence, the financial choice that remains available and the approval owner needed before a revised commercial or infrastructure commitment can be supported.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 11 October 2026. Mandate reference PCT-ADV-2026-IND-18.

More seats like this one

Every live mandate, by seat →

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.